Accuray Incorporated  

(Public, NASDAQ:ARAY)   Watch this stock  
Find more results for aray
6.37
+0.14 (2.25%)
After Hours: 6.30 -0.07 (-1.14%)
Sep 30, 4:40PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 6.12 - 6.39
52 week 4.75 - 7.54
Open 6.29
Vol / Avg. 995,802.00/786,091.00
Mkt cap 525.54M
P/E     -
Div/yield     -
EPS -0.32
Shares 81.57M
Beta 1.50
Inst. own 95%
Nov 18, 2016
Accuray Inc Annual Shareholders Meeting (Estimated) - 12:00PM EST - Add to calendar
Oct 27, 2016
Q1 2017 Accuray Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Sep 14, 2016
Accuray Inc at Morgan Stanley Global Healthcare Conference
Aug 17, 2016
Q4 2016 Accuray Inc Earnings Call - Webcast
Aug 17, 2016
Q4 2016 Accuray Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2016
Net profit margin -7.59% -6.40%
Operating margin -3.12% -1.22%
EBITD margin - 3.37%
Return on average assets -6.03% -5.45%
Return on average equity -47.39% -37.66%
Employees 959 -
CDP Score - -

Address

1310 Chesapeake Ter
SUNNYVALE, CA 94089-1100
United States - Map
+1-408-7164600 (Phone)
+1-408-7164601 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Accuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

Officers and directors

Louis J. Lavigne Jr. Independent Chairperson of the Board
Age: 68
Bio & Compensation  - Reuters
Joshua H. Levine President, Chief Executive Officer, Director
Age: 57
Bio & Compensation  - Reuters
Elizabeth H. Davila Independent Vice Chairperson of the Board
Age: 71
Bio & Compensation  - Reuters
Kevin Waters Chief Financial Officer, Senior Vice President
Age: 38
Bio & Compensation  - Reuters
Kelly J Londy Chief Operating Officer, Executive Vice President
Age: 48
Bio & Compensation  - Reuters
Alaleh Nouri Senior Vice President, General Counsel, Corporate Secretary
Age: 36
Bio & Compensation  - Reuters
Jack Goldstein Ph.D. Independent Director
Age: 68
Bio & Compensation  - Reuters
Richard R. Pettingill Independent Director
Age: 67
Bio & Compensation  - Reuters
Robert S. Weiss Independent Director
Age: 69
Bio & Compensation  - Reuters
Dennis L. Winger Independent Director
Age: 67
Bio & Compensation  - Reuters